Not applicableEnded earlyNCT06155513What this trial is testingOmega-3 Monoglyceride Based Topic Products as Skin Prebiotics for EczemaWho this might be right forEczema SCF Pharma 7
Early research (Phase 1)Study completedNCT03183830What this trial is testingInfluence of Dietary Nitrate on Skin InflammationWho this might be right forCardiovascular DiseasesInflammationInflammation; Skin+2 more Queen Mary University of London 24
Large-scale testing (Phase 3)Active Not RecruitingNCT04799275What this trial is testingTesting CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell LymphomaWho this might be right forAnn Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IIX (Bulky) Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma+18 more National Cancer Institute (NCI) 422
Not applicableWithdrawnNCT03862872What this trial is testingEffects of Bend Beauty's Anti-Aging Formula on Inflammatory MarkersWho this might be right forInflammationSkin AbnormalitiesSkin Pigment+2 more Bend Beauty Inc.
Large-scale testing (Phase 3)Study completedNCT01640951What this trial is testing4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type PsoriasisWho this might be right forModerate to Severe Chronic Plaque-Type Psoriasis Novartis Pharmaceuticals 675
Not applicableLooking for participantsNCT05928169What this trial is testingDeterminants of Chronic Inflammatory Skin Disease TrajectoriesWho this might be right forAtopic DermatitisPsoriasisLichen Planus+5 more University Hospital Schleswig-Holstein 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT06799000What this trial is testingAssess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)Who this might be right forHidradenitis Suppurativa Novartis Pharmaceuticals 588
Early research (Phase 1)Study completedNCT01539213What this trial is testingDistribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mgWho this might be right forHealthyPsoriasis Novartis Pharmaceuticals 16
Early research (Phase 1)Study completedNCT05461456What this trial is testingBioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%Who this might be right forAtopic DermatitisAtopic Dermatitis EczemaAtopic Rash+9 more OrchestratePharma GmbH 12
Not applicableUnknownNCT05500794What this trial is testingMeditation in Inflammatory DermatosisWho this might be right forAtopic DermatitisPsoriasisPruritus Assistance Publique - Hôpitaux de Paris 72
Not applicableEnded earlyNCT01663571What this trial is testingSTAT3 in T Cells: At The Crossroads of Inflammation and CancerWho this might be right forCutaneous T Cell Lymphoma NYU Langone Health 35
Testing effectiveness (Phase 2)WithdrawnNCT03976206What this trial is testingVery Small Embryonic-like Stem Cells for Facial Skin AntiagingWho this might be right forStem Cell Transplant ComplicationsSkin Inflammation Fuda Cancer Hospital, Guangzhou
Large-scale testing (Phase 3)Study completedNCT01412944What this trial is testingEfficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type PsoriasisWho this might be right forPlaque-type Psoriasis Novartis Pharmaceuticals 43
Not applicableStudy completedNCT00162825What this trial is testingRole of CD7 in Skin Inflammation and PsoriasisWho this might be right forPsoriasisInflammation National Taiwan University Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05535738What this trial is testingUsing a Contact Dermatitis Model With Biologic Medications to Study Skin InflammationWho this might be right forSkin InflammationAllergic Contact Dermatitis Wei-Che Ko 45
Testing effectiveness (Phase 2)Study completedNCT01519778What this trial is testingSafety and Exploratory Skin Lesion Measurement of TR-701 FA StudyWho this might be right forMajor Cutaneous AbscessCellulitisErysipelas Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 200
Not applicableStudy completedNCT03192280What this trial is testingSkin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin ResponseWho this might be right forSkin Inflammation LEO Pharma 12
Large-scale testing (Phase 3)Study completedNCT01358578What this trial is testingSafety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type PsoriasisWho this might be right forChronic Plaque Psoriasis Novartis Pharmaceuticals 1,306
Not applicableLooking for participantsNCT07021495What this trial is testingSKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)Who this might be right forChronic Spontaneous Urticaria (CSU)Hidradenitis Suppurativa (HS)Psoriasis (PsO)+2 more Leiden University Medical Center 840
Post-approval studies (Phase 4)Study completedNCT00352612What this trial is testingComparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin InfectionsWho this might be right forStaphylococcal InfectionAbscessStaphylococcal Skin Infection+1 more Aaron Chen 200